Tags: epilepsy | drug | lundbeck | sabril

Epilepsy Treatment for Kids

Monday, 28 October 2013 03:59 PM

Danish pharmaceutical group Lundbeck has won approval in the United States of its epilepsy drug, Sabril, to be used in children aged 10 years and older.
 
Lundbeck said in a statement the United States Food and Drug Administration (FDA) had approved Sabril as an add-on therapy for the treatment of refractory complex partial seizures in children who have inadequately responded to several other treatments.

© 2018 Thomson/Reuters. All rights reserved.

Click Here to comment on this article
   
1Like our page
2Share
Share
FDA-Approved-Drugs
Lundbeck has won approval in the United States of its epilepsy drug, Sabril, to be used in children aged 10 years and older.
epilepsy,drug,lundbeck,sabril
64
2013-59-28
Monday, 28 October 2013 03:59 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved